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The Nationwide Inpatient Sample may contain
inaccurate data for carotid endarterectomy and
carotid stenting
Norman R. Hertzer, MD, Beachwood, Ohio
The Nationwide Inpatient Sample (NIS) contains information from discharge abstracts submitted by hundreds of
community hospitals across the United States, and it frequently has been used as a resource for population-based research
comparing the safety of carotid artery stenting (CAS) to that of carotid endarterectomy (CEA). However, at least two
findings from the NIS dataset seem open to question. First, several NIS studies have indicated that more than 90% of
CEAs andCAS procedures now are being done in asymptomatic patients, a figure that substantially exceeds the prevalence
of asymptomatic patients that has been reported elsewhere. Second, these studies also have suggested that the
periprocedural stroke rate for CEA and CAS is lower at community hospitals contributing to the NIS than it was in the
Carotid Revascularization Endarterectomy vs Stenting Trial (CREST), even though the surgeons and interventionalists
participating in CREST were stringently selected according to their previous experience and results. Neither of these two
findings seems to pass the test of face validity. Furthermore, some unexpectedly low stroke-to-death (STD) ratios are
present in the NIS data, especially for CAS. These issues may be related to poor documentation of preprocedural
symptoms and periprocedural strokes in the medical records and to subsequent coding errors in the hospital discharge
abstracts on which the NIS is based. (J Vasc Surg 2012;55:263-7.)
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aThe Nationwide Inpatient Sample (NIS) is the largest
all-payer inpatient care database publicly available in the
United States, containing diagnostic, procedural, and out-
come data for 5 to 8 million annual admissions to about
1000 nonfederal acute care facilities that represent approx-
imately a 20% sample of U.S. community hospitals.1 Like
other administrative datasets, however, information in the
NIS is generated directly from discharge abstracts designed
to facilitate hospital payment. These abstracts customarily
are prepared by trained coding specialists who assign Inter-
national Classification of Diseases, Ninth Revision, Clinical
Modification (ICD-9-CM) codes after reviewing inpatient
medical records to capture provider care and services that
warrant reimbursement. Therefore, although NIS data are
used for influential population-based outcomes research,
they are subject to potential oversights in documentation
and coding.
From the Department of Vascular Surgery, Cleveland Clinic Emeritus
Office.
Competition of interest: none.
Reprint requests: Norman R. Hertzer, MD, Department of Vascular Sur-
gery, Cleveland Clinic, Emeritus Office, 3050 Science Park Drive/
AC334, Beachwood, OH 44122 (e-mail: hertzen@ccf.org).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00S
Copyright © 2012 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2011.08.059Six studies investigating the “real world” safety of
arotid artery stenting (CAS) compared to carotid endar-
erectomy (CEA) raise questions about the accuracy of the
IS dataset.2-7 First, each reported that over 90% of the
EAs and CAS procedures in the NIS were performed in
symptomatic patients, a finding that is inconsistent with
uch of the literature on this topic. Second, their peripro-
edural stroke rates (CEA, 0.9% to 2.7%; CAS, 1.4% to
.2%) are comparable or superior to those (CEA, 2.3%;
AS, 4.1%) in the Carotid Revascularization Endarter-
ctomy vs Stenting Trial (CREST) despite the fact that
REST certified only experienced surgeons and carefully
etted its interventionalists.8 These issues deserve fur-
her consideration.
SYMPTOMATIC PATIENTS
Table I shows the prevalence of asymptomatic stenosis
s an indication for carotid intervention in the six NIS
tudies as well as in five state-wide surveys that also were
ased on claims data.9-12 These are compared to four other
ulticentered sources for which information was submit-
ed by attending physicians13 or was gathered in the con-
ext of validated investigations.14-16 The prevalence of
symptomatic patients in NIS studies ranges from 92% to
n astonishing 97%, and a preponderance of asymptomatic
atients also is present in state-wide data. In comparison,
he prevalence of asymptomatic patients is from 20% to
s much as 30% lower in contemporary reports from the
ociety for Vascular Surgery (SVS) Vascular Registry,13
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January 2012264 Hertzerthe Vascular Study Group of Northern New England,14
the CREST lead-in phase,15 and the New York Carotid
Artery Surgery Study.16
It seems safe to assume that an increasing majority of
CAS procedures has been performed for asymptomatic
stenosis since 2006, the year in which the Endarterectomy
versus Angioplasty in Patients with Symptomatic Severe
Carotid Stenosis (EVA-3S) trial first indicated that CAS has
a significantly higher stroke risk in symptomatic patients.17
This does not explain the prevalence of asymptomatic pa-
tients in the NIS studies in Table I, however, because data
for five of themwere collected before 2006.3-7 Even if these
data are manipulated to simulate that all CAS procedures
were done in asymptomatic patients, from 91% to 97% of
the CEA patients still would have had asymptomatic steno-
sis. In summary, the overwhelming predominance of
asymptomatic patients in NIS studies seems unreasonable.
All NIS studies in Table I used a standard approach for
searching the NIS dataset, relying on the accuracy of ICD-
9-CM coding to distinguish symptomatic from asymptom-
atic patients. The code for “occlusion or stenosis of the
carotid artery” is intended for use in conjunction with
either of two subclassifications, one being “with stroke”
and the other “without mention of stroke.” If the primary
diagnosis fails to specify a previous stroke, a patient is
Table I. The proportion of asymptomatic patients underg
administrative datasets compared to other multicentered so
Data source Study period C
NIS
Eslami et al2 2005-2007 35
Timaran et al3 2005 12
Vogel et al4a 2005 7
McPhee et al5 2005 12
Rockman et al6 2004-2005 5
McPhee et al7 2003-2004 24
Statewide surveys
Giacovelli et al9 (New York and
California) 2005-2007 4
Vogel et al10 (New Jersey) 2005-2006
Steppacher et al11 (New York
and Florida) 2005-2006
Matsen et al12 (California) 1999-2003 5
Matsen et al12 (Maryland) 1994-2003 2
Other multicentered sources
Sidawy et al13 (Society for
Vascular Surgery Vascular
Registry) 2005-2007
Goodney et al14 (Vascular Study
Group of Northern New
England) 2003-2007
Hobson et al15 (CREST lead-in
phase) 2000-2004
Halm et al16 (New York Carotid
Artery Surgery Study) 1998-1999
CAS, Carotid artery stenting;CEA, carotid endarterectomy;CREST, Caroti
Sample; NR, not reported.
aAge 60, procedure within 48 hours of hospital admission.considered to be asymptomatic by the NIS unless a hospital roder can find a secondary diagnosis like “stroke,” “tran-
ient cerebral ischemia” or “amaurosis fugax,” or a surro-
ate descriptor like “transient paralysis of limb” or “tran-
ient visual loss” to indicate otherwise.4 It is necessary for
linicians to clearly place these terms in the medical records
here the coding staff will find them while preparing the
ischarge abstract, but this does not always happen.
Having audited inpatient records from many hospitals
uring peer review activities, this writer is impressed by how
requently discharge abstracts contain the diagnosis “ca-
otid stenosis” without any documentation whatsoever in
he admitting history, operative report, progress notes, or
ischarge summary to indicate whether it was associated
ith preoperative symptoms. This could cause symptom-
tic patients to be entered in the NIS as being asymptom-
tic by default. If it occurs often enough, the inclusion of
ymptomatic patients among asymptomatic patients would
ake the low periprocedural stroke rates in NIS studies
ven more difficult to understand.
ERIPROCEDURAL STROKES
One of the confounding features of the NIS dataset is
hat it fails to include strokes occurring after hospital dis-
harge but within the 30-day periprocedural period used by
ther studies. The incidence of interim events is rarely
carotid endarterectomy or carotid stenting in
s of information
Number of procedures Asymptomatic stenosis as
indication for
interventionCAS Total
46,198 404,256 92
13,093 135,903 92
6569 80,498 97
12,914 135,701 92
3183 54,658 94
14,035 259,080 92
6360 47,752 91
625 625 96
4001 4001 91
NR 51,331 85
NR 23,237 85
2763 6403 57
NR 3092 56
749 749 69
NR 9308 72
scularization Endarterectomy vs Stenting Trial;NIS, Nationwide Inpatientoing
urce
EA
8,058
2,984
3,929
2,786
1,427
5,045
1,392
NR
NR
1,331
3,237
3259
3092
NR
9308
d Revaeported elsewhere, but the SVS Vascular Registry suggests
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Volume 55, Number 1 Hertzer 265that 29% of the 30-day strokes after CEA and 43% of those
after CAS happen after patients leave the hospital.13 How-
ever, another multicentered registry maintained by the
Vascular Study Group of Northern New England indi-
cates that only 10% of the 30-day strokes after CEA occur
after hospital discharge.14 Conflicting data from so few
available resources make it difficult to establish a legiti-
mate adjustment factor with which to estimate 30-day
stroke rates for NIS studies, even though it might possi-
bly make them more comparable to randomized clinical
trials.
Table II shows the periprocedural stroke and death
rates from five NIS studies in which such outcomes have
been stratified for symptomatic and asymptomatic pa-
tients.2,3,5-7 These results are compared to the outcomes in
four randomized trials of CAS and CEA, including
CREST,8 EVA-3S,17 the Stent-Supported Percutaneous
Angioplasty of the Carotid Artery versus Endarterectomy
(SPACE) trial,18 the International Carotid Stenting Study
(ICSS),19 and a meta-analysis of individual patient data
from EVA-3S, SPACE, and ICSS.20 Stroke-to-death ratios
also have been calculated whenever possible. It should be
noted that the volume of procedures in the NIS is so
large that anomalous event rates for symptomatic pa-
tients in Table II cannot easily be explained on the basis
of sample size. On the unlikely assumption that only 6%
to 8% of NIS patients were symptomatic, from 9822 to
Table II. Periprocedural stroke and death rates reported f
symptomatic and asymptomatic patients in the NIS and ran
Data source Study period Stroke
Symptomatic patients
NIS
Eslami et al2 2005-2007 2.1
Timaran et al3 2005 2.6
McPhee et al5 2005 2.5
Rockman et al6 2004-2005 2.6
McPhee et al7 2003-2004 1.1
Randomized trials
EVA-3S17 2000-2005 2.7
SPACE18 2001-2006 6.2
ICSS19 2001-2008 4.1
Collaborative meta-analysis (EVA-3S,
SPACE, ICSS)20 2000-2008 4.9
CREST8 2000-2008 3.2
Asymptomatic patients
NIS
Eslami et al2 2005-2007 0.9
Timaran et al3 2005 1.0
McPhee et al5 2005 0.9
Rockman et al6 2004-2005 0.9
McPhee et al7 2003-2004 0.9
Randomized trials
CREST8 2000-2008 1.4
CREST, Carotid Revascularization Endarterectomy vs Stenting Trial; EVA
Carotid Stenosis Trial; ICSS, International Carotid Stenting Study; NA
Percutaneous Angioplasty of the Carotid Artery versus Endarterectomy Tria28,644 CEAs and 1033 to 3695 CAS procedures still sere done for symptomatic indications in four of the NIS
tudies.2,3,5,7
In symptomatic patients, periprocedural stroke rates
anged from 1.1% to 2.6% for CEA and from 3.1% to 5.0%
or CAS in the NIS studies, compared to 3.2% and 5.5%,
espectively, in CREST and from 2.7% to 6.2% for CEA and
rom 7.5% to 8.8% for CAS in other randomized trials. In
symptomatic patients, the stroke rates for CEA (0.9% to
.0%) and CAS (1.3% to 1.9%) in NIS studies were uni-
ormly better than those (1.4% and 2.5%, respectively) in
REST. Whereas stroke rates in the NIS tend to be lower
han in trials, the death rates for symptomatic CAS patients
n the NIS (range, 3.9% to 7.5%) instead were considerably
igher than in trials (range, 0.8% to 2.3%). This results in an
nusual stroke-to-death (STD) ratio in these patients.
Because most perioperative strokes associated with
EA are not fatal, its STD ratio should be well above 1:1.
ccording to data from the SVS Vascular Registry13 and
REST,8 the same relationship would be expected for
AS. The STDs in the SVS data are 3:1 for CEA and 2.4:1
or CAS in symptomatic patients and 1.9:1 for CEA and
.1:1 for CAS in asymptomatic patients.13 Periprocedural
ortality rates have not yet been reported separately for
he symptomatic and asymptomatic patients in CREST,
ut its overall STD ratio can be calculated to be 7.2:1 for
EA (29 strokes, 4 deaths) and 5.8:1 for CAS (52
rotid endarterectomy and carotid stenting in
ized trials
tid endarterectomy Carotid stenting
Death (%) STD ratio Stroke (%) Death (%) STD ratio
1.2 1.8:1 3.1 3.9 0.8:1
1.4 1.9:1 5.0 4.6 1.1:1
1.4 1.8:1 4.1 4.6 0.9:1
2.5 1.0:1 5.0 6.1 0.8:1
1.0 1.1:1 4.2 7.5 0.6:1
1.2 2.2:1 8.8 0.8 11:1
0.9 7.2:1 7.5 0.7 11:1
0.8 5.1:1 7.7 2.3 3.3:1
1.3 3.8:1 8.2 1.9 4.3:1
NA — 5.5 NA —
0.4 2.2:1 1.3 0.6 2.2:1
0.5 2:1 1.8 0.7 2.6:1
0.4 2.2:1 1.6 0.6 2.7:1
0.4 2.2:1 1.9 0.5 3.8:1
0.3 3:1 1.8 0.4 4.5:1
NA — 2.5 NA —
Endarterectomy versus Angioplasty in Patients with Symptomatic Severe
available; NIS, Nationwide Inpatient Sample; SPACE, Stent-Supported
, stroke-to-death ratio.or ca
dom
Caro
(%)
-3S,trokes, 9 deaths).8
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Table II. First, STD ratios for symptomatic patients in the
NIS are substantially lower than for asymptomatic NIS
patients even though symptomatic patients ordinarily have
more periprocedural strokes. Second, STD ratios for symp-
tomatic NIS patients also are low in comparison to symp-
tomatic patients in randomized trials, especially among
those who had CAS. In this subset, the STD ratios in NIS
studies ranged only from 0.6:1 to 1.1:1, compared to a
range of 3.3:1 to 11:1 in the trials. There is no obvious
clinical explanation for this, so it may be related to errors in
documentation and/or coding. Either too few strokes or
toomany deaths seem to be present in certain subsets of the
NIS data. It would be practically impossible for a hospital
coder to mistakenly enter a death while preparing a dis-
charge abstract, so strokes are more logical sources of error.
CONCLUSION
In addition to the absence of 30-day event rates, the
author must conclude that preprocedural symptoms and
periprocedural strokes are under-reported in the NIS on
the basis of coding errors and/or a lack of clarity with which
these events are documented in medical records. The only
alternatives are to believe that as few as 3% of patients are
symptomatic before CEA or CAS, and that the stroke risks
of these procedures are collectively lower at a thousand
community hospitals in the NIS than they are in CREST.
Neither of these alternatives seems plausible.
The author gratefully acknowledges Jacqueline Mat-
thews, RN, MS, Director of External Quality Reporting at
the Cleveland Clinic, for reviewing the manuscript regard-
ing the process of ICD-9-CM coding in hospital discharge
abstracts.
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Dr Hertzer has presented an insightful article demonstrating
the shortcomings of administrative data research and the variation
ndings, is a well-documented phenomenon in all administrative
ata studies.1,2 TheNIS is well suited for “hard” end points such as
ortality rates, procedures, and discharge disposition, but the
oding of comorbidities and complications is often variable.
